Sana Biotechnology, Inc. (SANA)
5.04
+0.10
(+2.02%)
USD |
NASDAQ |
Dec 11, 12:26
Sana Biotechnology EPS Diluted (Quarterly): -0.1618 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Illumina, Inc. | 0.974 |
| Pacific Biosciences of California, Inc. | -0.1263 |
| Editas Medicine, Inc. | -0.2788 |
| Intellia Therapeutics, Inc. | -0.9196 |
| CEL-SCI Corp. | -1.365 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.15M |
| Total Expenses (Quarterly) | 42.15M |
| Enterprise Value | 1.241B |
| Earnings Yield | -19.26% |
| Normalized Earnings Yield | -16.46 |